To access this element change to forms mode OFF
Grant Award View - GA217031
Dissecting the challenge of AML
GA ID:
GA217031
Agency:
National Health and Medical Research Council (NHMRC)
Approval Date:
17-Oct-2021
Publish Date:
7-Feb-2022
Category:
Medical Research
Grant Term:
1-Jan-2022 to 31-Dec-2025
Value (AUD):
$149,767.02
(GST inclusive where applicable)
One-off/Ad hoc:
No
Aggregate Grant Award:
No
PBS Program Name:
NHMRC 20/21 1.1 Health and Medical Research
Grant Program:
Postgraduate Scholarships
Grant Activity:
Dissecting the challenge of AML
Purpose:
Acute myeloid leukaemia (AML) is a life-threatening blood cancer that is difficult to treat. Recently, several new “targeted therapy†drugs have been developed, which work by blocking specific changes in cancer cells that help them survive and grow. Unfortunately, resistance to treatment commonly emerges. This project aims to understand how resistance can arise and how they affect responsiveness to different drugs. This information will help us develop better treatments for patients with AML.
GO ID:
GO Title:
2021 NHMRC Postgraduate Scholarship scheme
Internal Reference ID:
2021/GNT2014234
Selection Process:
Targeted or Restricted Competitive
Confidentiality - Contract:
Yes
Confidentiality Reason(s) - Contract:
Privacy Act 1988
Intellectual property
Intellectual property
Confidentiality - Outputs:
Yes
Confidentiality Reason(s) - Outputs:
Intellectual property
Grant Recipient Details
Recipient Name:
The Walter and Eliza Hall Institute of Medical Research
Recipient ABN:
12 004 251 423
Grant Recipient Location
Suburb:
Parkville
Town/City:
Parkville
Postcode:
3052
State/Territory:
VIC
Country:
AUSTRALIA
Grant Delivery Location
State/Territory:
VIC
Postcode:
Country:
AUSTRALIA